Cameron Turtle, Chief Business Officer at Eidos Therapeutics, Inc. (EIDX), sold 2,500 shares at $47.00 ($118K) on 2020-09-10, disclosed to the SEC on 2020-09-11.
Open-market sale of $118k EIDX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |